News : 2016 : August

Noriyuki Kasahara, M.D., Ph.D.

Ingenious Brain Tumor Therapy Found Safe and Effective in Early Trial

A Phase I dose-escalation trial, conducted at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and multiple sites nationwide, has shown that a new gene therapy treatment for high-grade gliomas — the most aggressive brain tumors — is safe and improves patient survival. Having passed this milestone, the treatment will move on to more advanced trials.

Read more »

Miller School of Medicine, Schoninger Research Quadrangle

Miller School of Medicine Has Record-Breaking Fundraising Year

Continuing an upward trend, the University of Miami Miller School of Medicine reached a record-breaking fundraising total for the fiscal year 2016. According to standards set by the Council for Advancement and Support of Education (CASE), the Miller School raised an unprecedented $159.8 million for the fiscal year, which ended May 31.

Read more »